• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?

作者信息

Glutsch V, Kneitz H, Goebeler M, Gesierich A, Schilling B

机构信息

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

出版信息

Ann Oncol. 2019 Oct 1;30(10):1667-1668. doi: 10.1093/annonc/mdz230.

DOI:10.1093/annonc/mdz230
PMID:31350554
Abstract
摘要

相似文献

1
Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?在转移性默克尔细胞癌中联合使用伊匹木单抗和纳武单抗打破阿维鲁单抗耐药性？
Ann Oncol. 2019 Oct 1;30(10):1667-1668. doi: 10.1093/annonc/mdz230.
2
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma.伊匹木单抗联合纳武单抗治疗阿维鲁单抗难治性默克尔细胞癌的活性
Cancer Immunol Immunother. 2021 Jul;70(7):2087-2093. doi: 10.1007/s00262-020-02832-0. Epub 2021 Jan 13.
3
Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients.HIV 阳性患者转移性黑色素瘤和默克尔细胞癌的检查点阻断治疗
Ann Oncol. 2017 Dec 1;28(12):3104-3106. doi: 10.1093/annonc/mdx538.
4
Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: Any role for sequential immunotherapy?在对阿维鲁单抗难治的转移性默克尔细胞癌中，使用伊匹木单抗和纳武单抗再次治疗后实现持久缓解：序贯免疫疗法有何作用？
J Dermatol. 2021 Feb;48(2):e80-e81. doi: 10.1111/1346-8138.15621. Epub 2020 Nov 7.
5
Quality of life and patient-reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy.接受纳武利尤单抗联合伊匹单抗联合或不联合立体定向体部放射治疗的晚期 Merkel 细胞癌患者的生活质量和患者报告的毒性。
Cancer Med. 2024 Jul;13(14):e7464. doi: 10.1002/cam4.7464.
6
Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical Trial.初治转移性默克尔细胞癌患者接受avelumab 治疗的体验：来自 JAVELIN Merkel 200 注册临床研究的纵向定性访谈结果。
Patient. 2020 Aug;13(4):457-467. doi: 10.1007/s40271-020-00428-5.
7
Combined immunotherapy with ipilimumab plus nivolumab in metastatic PD-1/PD-L1-refractory Merkel cell carcinoma-a case report.伊匹单抗联合纳武单抗用于转移性PD-1/PD-L1难治性默克尔细胞癌的联合免疫疗法——病例报告
Int J Dermatol. 2024 Feb;63(2):e69-e71. doi: 10.1111/ijd.16986. Epub 2023 Dec 13.
8
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.纳武利尤单抗联合伊匹单抗联合或不联合立体定向体部放疗治疗晚期 Merkel 细胞癌：一项随机、开放标签、Ⅱ期临床试验。
Lancet. 2022 Sep 24;400(10357):1008-1019. doi: 10.1016/S0140-6736(22)01659-2. Epub 2022 Sep 12.
9
Combined nivolumab and ipilimumab in non-resectable Merkel cell carcinoma.纳武利尤单抗与伊匹木单抗联合治疗不可切除的默克尔细胞癌。
Lancet. 2022 Sep 24;400(10357):976-977. doi: 10.1016/S0140-6736(22)01749-4. Epub 2022 Sep 12.
10
Avelumab for the treatment of metastatic Merkel cell carcinoma.阿维鲁单抗用于治疗转移性默克尔细胞癌。
Drugs Today (Barc). 2017 Jul;53(7):377-383. doi: 10.1358/dot.2017.53.7.2654888.

引用本文的文献

1
Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence.非黑色素瘤皮肤癌中的免疫检查点抑制：当前证据综述
Front Oncol. 2021 Dec 20;11:734354. doi: 10.3389/fonc.2021.734354. eCollection 2021.
2
T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options.默克尔细胞癌中的 T 细胞反应：对改善免疫检查点阻断和其他治疗选择的意义。
Int J Mol Sci. 2021 Aug 12;22(16):8679. doi: 10.3390/ijms22168679.
3
Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report.
默克尔细胞癌中阿维鲁单抗的长期反应及寡进展管理：一例报告
World J Clin Cases. 2021 Jun 26;9(18):4829-4836. doi: 10.12998/wjcc.v9.i18.4829.
4
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma.伊匹木单抗联合纳武单抗治疗阿维鲁单抗难治性默克尔细胞癌的活性
Cancer Immunol Immunother. 2021 Jul;70(7):2087-2093. doi: 10.1007/s00262-020-02832-0. Epub 2021 Jan 13.
5
Current concepts and approaches to merkel cell carcinoma.默克尔细胞癌的当前概念和方法。
Arch Dermatol Res. 2021 Apr;313(3):129-138. doi: 10.1007/s00403-020-02107-9. Epub 2020 Jul 14.